1)  Laminin
板层素
2)  Lamellar
板层
1.
A primary mlticenter report of lamellar keratoplasty in treatment of keratoconus;
部分板层角膜移植治疗圆锥角膜多中心研究的初步报告
2.
Objective: To investigate the feasibility of lamellar keratoplasty combined with photorefractive keratectomy(PRK) and phototherapeutic keratectomy(PTK)and provide theoretical basis for clinical study.
目的:探索准分子激光角膜屈光手术联合板层角膜移植术的可行性,为临床研究提供理论依据。
3.
Objective: We tried to identify the genetic defect causing Hereditary lamellar Cataract.
目的:遗传性板层白内障家系致病基因的定位及突变筛查。
3)  LaminaⅡ
Ⅱ板层
4)  TLC
薄板层析
1.
This experiment adopts the TLC to proceed the separation of the first step to the Monascus sample, lowering the interference of pigment, according to citrinin oneself have fluorescent characteristic under excitation state , combination fluorescence examination, adopts the method of HPLC to proceed successfully the measurement the citrinin deal of the Fujian Monascus produce.
采用薄板层析对红曲样品进行初步的分离,降低了红曲中色素的干扰,根据桔霉素本身具有在激发态下产生荧光的特性,结合荧光检测采用反相HPLC法较为成功地测出福建红曲中桔霉素的含量。
2.
Method: The mole fraction of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) in total phospholipids of CBRH-7919 hepatoma cells was compared to that of normal liver cells by high performance thin layer chromatography (HPTLC) and phosphorus assay.
方法 :采用高效薄板层析方法并配合无机磷的测定 ,比较了大鼠正常肝细胞与癌变细胞磷脂的组成及摩尔分数 ,用气相色谱法对其中含量最多的磷脂组分磷脂酰胆碱 (PC)的脂肪酸组成进行了测定。
5)  TLC
板层析
6)  Lamellar bodies
板层体
1.
Result Lamellar bodies were scattered in the nasal mucosa and they were circular,lamellar-and coil-like small bodies with compact electron densities.
目的观察鼻黏膜表面活性物质板层体的超微结构。
2.
Methods Morphometric analysis and Northern blot were used to study the numbers of the lamellar bodies of alveolar type Ⅱ cells and the expression of surfactant associated protein(SP) A, B and C genes in lung tissues from young (1-2 months),adult (9-10 months) and old (25-28 months)rats.
方法 利用形态计量和Northern杂交方法比较了幼(1~2月龄)、中(9~10月龄)和老年(25~28月龄)大鼠肺泡Ⅱ型细胞内板层体数及肺组织内肺泡表面活性物质相关蛋白(SP)A、B和C基因的表达。
参考词条
补充资料:紫杉醇 ,紫素,特素,紫烷素,路泰,泰素
药物名称:红豆杉醇

英文名:Taxol

别名: 红豆杉醇;紫杉醇 ,紫素,特素,紫烷素,路泰,泰素
外文名:Taxol ,TAX,Paclitaxel,PTX
适应症: 本品适用于一线或其后的卵巢转移性癌化疗失败以后的治疗。
用量用法:
稀释的泰素注射液应先经过所连接的直径不超过0.22μm孔膜的滤过装置,使用前先用地噻米松、苯海拉明及H2一受体拮抗剂。
注意事项:
1.可有白细胞、血小板减少、贫血(血色素减少)、感染、粘膜炎、出血、过敏反应、低血压、心动过缓、心电图异常、关节痛、肌肉痛、转氨酶和胆红素升高、脱发、恶心及呕吐。 2.对本品有过敏者及骨髓抑制患者忌用。
规格: 浓缩注射液:30mg/支。


类别:抗肿瘤植物成分药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。